| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |